Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Tscharke

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Expert Opinion on Biological Therapy|March 11, 2005
From mice to humans - murine intelligence for human CD8+ T cell vaccine designDavid C Tscharke, Andreas Suhrbier
Journal of Virology|November 29, 2019
Herpes Simplex Virus Latency Is Noisier the Closer We LookNavneet Singh, David C Tscharke
The Journal of General Virology|November 26, 1999
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnaeDavid C Tscharke, Geoffrey L Smith
Nature Medicine|June 5, 2003
T cells bite the hand that feeds themDavid C Tscharke, Jonathan W Yewdell
Biotechniques|July 26, 2002
Notes on transient host range selection for engineering vaccinia virus strain MVADavid C Tscharke, Geoffrey L Smith
Plos Pathogens|June 28, 2016
Lytic Promoters Express Protein during Herpes Simplex Virus LatencyTiffany A Russell, David C Tscharke
The Journal of General Virology|October 23, 2013
Truncation of gene F5L partially masks rescue of vaccinia virus strain MVA growth on mammalian cells by restricting plaque sizeBianca M Dobson, David C Tscharke
Immunology and Cell Biology|February 26, 2014
Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c miceTiffany A Russell, David C Tscharke
Molecular Immunology|July 21, 2023
BMX-A and BMX-S: Accessible cell-free methods to estimate peptide-MHC-I affinity and stabilityMatthew J Witney, David C Tscharke
The Journal of General Virology|August 21, 2015
Redundancy complicates the definition of essential genes for vaccinia virusBianca M Dobson, David C Tscharke
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Expert Opinion on Biological Therapy|March 11, 2005
From mice to humans - murine intelligence for human CD8+ T cell vaccine designDavid C Tscharke, Andreas Suhrbier
Journal of Virology|November 29, 2019
Herpes Simplex Virus Latency Is Noisier the Closer We LookNavneet Singh, David C Tscharke
The Journal of General Virology|November 26, 1999
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnaeDavid C Tscharke, Geoffrey L Smith
Nature Medicine|June 5, 2003
T cells bite the hand that feeds themDavid C Tscharke, Jonathan W Yewdell
Biotechniques|July 26, 2002
Notes on transient host range selection for engineering vaccinia virus strain MVADavid C Tscharke, Geoffrey L Smith
Plos Pathogens|June 28, 2016
Lytic Promoters Express Protein during Herpes Simplex Virus LatencyTiffany A Russell, David C Tscharke
The Journal of General Virology|October 23, 2013
Truncation of gene F5L partially masks rescue of vaccinia virus strain MVA growth on mammalian cells by restricting plaque sizeBianca M Dobson, David C Tscharke
Immunology and Cell Biology|February 26, 2014
Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c miceTiffany A Russell, David C Tscharke
Molecular Immunology|July 21, 2023
BMX-A and BMX-S: Accessible cell-free methods to estimate peptide-MHC-I affinity and stabilityMatthew J Witney, David C Tscharke
The Journal of General Virology|August 21, 2015
Redundancy complicates the definition of essential genes for vaccinia virusBianca M Dobson, David C Tscharke
Pageof 11